The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant. [electronic resource]
Producer: 20020529Description: 1079-88 p. digitalISSN:- 0264-410X
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.